Neurocrine Biosciences NBIX
$ 125.62
0.5%
Quarterly report 2024-Q3
added 10-30-2024
Neurocrine Biosciences Cash Flow 2011-2024 | NBIX
Annual Cash Flow Neurocrine Biosciences
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
390 M | 339 M | 256 M | 228 M | 147 M | 101 M | -94.3 M | -106 M | - | - | -29.6 M | -35.3 M | -698 K |
Depreciation & Amortization |
17.8 M | 15.1 M | 10.9 M | 8.6 M | 7.4 M | 4.02 M | 2.4 M | 1.45 M | 1.01 M | 827 K | 671 K | 657 K | 694 K |
Accounts Payables |
- | - | - | - | - | - | 5.65 M | 5.08 M | 2.56 M | 246 K | 101 K | 911 K | 1.11 M |
Accounts Receivables |
439 M | 350 M | 186 M | 157 M | 127 M | 56.2 M | 31.1 M | - | - | - | 23 K | 14.1 M | 1.9 M |
Total Inventories |
38.3 M | 35.1 M | 30.5 M | 28 M | 17.3 M | 10.9 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Neurocrine Biosciences
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | 130 M | - | - | - | -125 M | - | 196 M | - | -40.5 M | - | 252 M | - | 87.3 M | - | 134 M | 154 M | 35.5 M | - | 49.5 M | -48.3 M | -112 M | - | 50.9 M | -18 M | -38.5 M | - | -135 M | -126 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.91 M | - | -26.4 M | -18.1 M | -11.2 M | - | -11.7 M | -14.5 M | -8.58 M |
Depreciation & Amortization |
- | - | 5.3 M | - | - | - | 4.1 M | - | 11.2 M | - | 3.3 M | - | 7.9 M | - | 2.5 M | - | 6.4 M | 4.2 M | 2.1 M | - | 5.4 M | 3.4 M | 1.57 M | - | 2.75 M | 1.67 M | 786 K | - | 1.69 M | 1.08 M | 489 K | - | 1.01 M | 600 K | 276 K | - | 739 K | 495 K | 244 K | - | 603 K | 386 K | 178 K | - | 515 K | 347 K | 175 K | - | 481 K | 318 K | 152 K | - | 552 K | 414 K | 240 K |
Accounts Payables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13.8 M | - | - | - | 5.65 M | - | - | 852 K | 5.08 M | 1.72 M | 1.76 M | 5.08 M | 2.56 M | 2.56 M | 2.56 M | 2.56 M | 246 K | 246 K | 246 K | 246 K | 101 K | 101 K | 101 K | 101 K | 911 K | 911 K | 911 K | 911 K | 1.11 M | 1.11 M | 1.11 M | 1.11 M |
Accounts Receivables |
481 M | 468 M | 451 M | 439 M | 418 M | 388 M | 392 M | 350 M | 301 M | - | 264 M | 186 M | 164 M | 158 M | 148 M | 157 M | 157 M | 157 M | 157 M | 127 M | 127 M | 127 M | 127 M | 57.4 M | 57.4 M | 56.2 M | 56.2 M | 31.1 M | 31.1 M | 31.1 M | 31.1 M | - | - | - | 15.1 M | - | - | - | 30 M | - | - | 2.92 M | 1.87 M | 2.72 M | 75 K | 38 K | 2.72 M | 14.1 M | 14.1 M | 14.1 M | 14.1 M | 1.9 M | 1.9 M | 1.9 M | 1.9 M |
Total Inventories |
45.8 M | 42.5 M | 37.2 M | 38.3 M | 28.8 M | 31.7 M | 33.4 M | 35.1 M | 37 M | - | 29 M | 30.5 M | 25.5 M | 28.3 M | 30.1 M | 28 M | 28 M | 28 M | 28 M | 17.3 M | 17.3 M | 17.3 M | 17.3 M | 10.9 M | 10.9 M | 10.9 M | 10.9 M | 1.02 M | 1.02 M | 128 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency